Reaction profile

The FDA adverse-event record for product defect, general

8,467 FDA adverse-event reports reference product defect, general (VeDDRA 99021). See the species, breeds, and drugs most associated with it below.

8,467
reports citing this reaction
0.7%
death-coded share
Unknown
most-affected species
Fluralaner Chew Tablets
most-associated drug
Verify with FDA CVM →
8,467
Total Reports
63
Deaths
0.7%
Death Rate

Species Most Affected

Unknown 7,384
Dog 882
Cat 92
Horse 38
Cattle 33
Human 15
Other 7
Other Birds 4
Pig 3
Sheep 2

Breeds Most Affected

Unknown 7,437
Dog (unknown) 181
Crossbred Canine/dog 103
Retriever - Labrador 58
Cat (unknown) 38
Chihuahua 37
Shih Tzu 36
Shepherd Dog - German 31
Domestic Shorthair 29
Retriever - Golden 28

Associated Drugs

Fluralaner Chew Tablets 1,210
Fluralaner 13.64% 12-Week Chew 1,049
Polysulfated Glycosaminoglycan 653
Pyrantel Pamoate;Sarolaner 308
Meloxicam 304
Device: Surgical Instruments 227
Ivermectin + Pyrantel As Pamoate Salt 222
Ivermectin + Pyrantel 219
Cyclosporine A 204
Nitenpyram 201
Lufenuron + Milbemycin Oxime 166
Praziquantel 155
Pimobendan 140
Milbemycin Oxime + Spinosad 130
Afoxolaner 109
Vetpen Starter Kit 107
Cyclosporine 100
Gentamicin Sulfate + Hydrocortisone Aceponate + Miconazole Nitrate 92
Equipment 82
Spinosad 76

Product Defect, General Reaction Insights

8,467 reports name Product Defect, General; 63 recorded a death outcome (0.7% of reported events, not a population-level mortality rate). VeDDRA code: 99021.

By species: Unknown (7,384 reports), Dog (882 reports), Cat (92 reports). By breed: Unknown (7,437), Dog (unknown) (181), Crossbred Canine/dog (103).

Most co-reported drugs: Fluralaner Chew Tablets (1,210 reports), Fluralaner 13.64% 12-Week Chew (1,049 reports), Polysulfated Glycosaminoglycan (653 reports), Pyrantel Pamoate;Sarolaner (308 reports).

Read these counts as reporting volume, not risk: per our methodology, co-reporting reflects temporal association captured in voluntary submissions, not proof that a drug caused this reaction. A widely-prescribed drug will rack up more raw co-reports at an identical true rate than a rarely-used one, so compare within similar-exposure products.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.